⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002032671

Dobek Maria

Reports to the SEC for 1 company · SAN DIEGO, CA

Transactions

6

Companies

1

Filings

3

CIK

0002032671

Forms 4 and 5

Insider transactions

6 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-11	JANXJanux Therapeutics, Inc.S Sale	Vice President, Accounting	SSale	−2,038 sh	$14.17	−$28.9K	32,270
2026-01-02	JANXJanux Therapeutics, Inc.S Sale	Vice President, Accounting	SSale	−1,462 sh	$13.73	−$20.1K	15,373
2026-01-02	JANXJanux Therapeutics, Inc.A Award	Vice President, Accounting	AAward	+18.9K sh	—	—	34,308
2026-01-02	JANXJanux Therapeutics, Inc. · Stock option (right to buy)A Award	Vice President, Accounting	AAward	+42.6K sh	—	—	42,600
2025-01-02	JANXJanux Therapeutics, Inc.A Award	Vice President, Accounting	AAward	+14K sh	—	—	14,001
2025-01-02	JANXJanux Therapeutics, Inc. · Stock option (right to buy)A Award	Vice President, Accounting	AAward	+31.5K sh	—	—	31,500

Recent filings

3

Accepted (ET)
May 134
Dobek Maria0002032671-26-000004
SEC(opens sec.gov)
Jan 24
Dobek Maria0002032671-26-000002
SEC(opens sec.gov)
Jan 34
Dobek Maria0001415889-25-000672
SEC(opens sec.gov)

Companies

1

Janux Therapeutics, Inc.Vice President, AccountingJANX

Address

C/O JANUX THERAPEUTICS, INC. 10955 VISTA SORRENTO PARKWAY, SUITE 200

SAN DIEGO, CA, 92130